Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), Ying Qing Chen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Myron S. Cohen(University of North Carolina at Chapel Hill), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Suwat Chariyalertsak(Chiang Mai University), Estelle Piwowar‐Manning(Johns Hopkins University), Marybeth McCauley(Family Health International 360), Ravindre Panchia(Chris Hani Baragwanath Hospital), Ethan Wilson(Fred Hutch Cancer Center), Joseph Makhema(Norwegian Womens Public Health Association), Theresa Gamble(University of Utah), José Henrique Pilotto(Universidade Iguaçu), Susan H. Eshleman(Johns Hopkins University), Philip J. Palumbo(Johns Hopkins University), Sheela Godbole(The Ohio State University Wexner Medical Center), Nagalingeswaran Kumarasamy(University of North Carolina at Chapel Hill), James Hakim(University of Zimbabwe), Mina C. Hosseinipour, Marineide Gonçalves de Melo(Hospital Nossa Senhora da Conceição), Jessica M. Fogel(Johns Hopkins University)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891